Results: The company had last reported an EBITDA margin in excess of 20% in the fourth quarter of financial year 2023.

Warren Buffett isn't known for his growth investing. Most experts would classify him as a value investor. But as Buffett has ...

Thus far in the month of January 2025, the BSE IPO index has tanked 11 per cent, as against 2.6 per cent decline in the BSE ...

Walmart's investment thesis has evolved from a stodgy dividend-paying value stock to a high-octane growth stock. With over 50 ...

Shares of Granules India Ltd. fell sharply on Friday after the pharmaceutical company reported a decline in its revenue and ...

Denta Water and Infra Solutions is selling its shares in the price band of Rs 279-294 apiece, which could be applied for a ...

A big question for UK investors is how much to pump into shares with the aim of achieving meaningful passive income down the ...

Mexicans are worried that threats by Donald Trump to impose 25% tariffs could affect a wide range of iconic products ...

U.S. stock futures were moving lower in early action on Friday, on the heels of the first record for the S&P 500 of 2024. Dow ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.